BROOKS LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of BROOKS LABORATORIES have increased by 3.86% YoY .
The Earnings Per Share (EPS) of BROOKS LABORATORIES has increased by Positive YoY. |
||
BROOKS LABORATORIES Last 5 Annual Financial Results
[BOM: 533543|NSE : BROOKS]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹83 Cr | ₹79 Cr | ₹63 Cr | ₹91 Cr | ₹77 Cr |
| Expenses | ₹81 Cr | ₹76 Cr | ₹90 Cr | ₹105 Cr | ₹77 Cr |
| Operating Profit (Excl OI) | ₹1.34 Cr | ₹3.06 Cr | ₹-26 Cr | ₹-14 Cr | ₹0.52 Cr |
| Other Income | ₹4.48 Cr | ₹1.11 Cr | ₹0.21 Cr | ₹0.80 Cr | ₹0.74 Cr |
| Interest | ₹1.03 Cr | ₹0.85 Cr | ₹2.18 Cr | ₹3.10 Cr | ₹3.10 Cr |
| Depreciation | ₹1.60 Cr | ₹1.77 Cr | ₹7.03 Cr | ₹7.35 Cr | ₹7.14 Cr |
| Profit Before Tax | ₹-9.79 Cr | ₹-20 Cr | ₹-38 Cr | ₹-24 Cr | ₹-8.99 Cr |
| Profit After Tax | ₹-9.97 Cr | ₹-20 Cr | ₹-31 Cr | ₹-19 Cr | ₹-19 Cr |
| Consolidated Net Profit | ₹-9.97 Cr | ₹-20 Cr | ₹-21 Cr | ₹-11 Cr | ₹-19 Cr |
| Earnings Per Share (Rs) | ₹8.35 | ₹-3.38 | ₹-7.46 | ₹-8.46 | ₹-4.57 |
| PAT Margin (%) | 28.67 | -12.07 | -24.65 | -49.12 | -21.18 |
| ROE(%) | 22.27 | -12.18 | -28.08 | -38.46 | -23.18 |
| ROCE(%) | 21.72 | -10.03 | -24.92 | -37.83 | -18.72 |
| Total Debt/Equity(x) | 0.06 | 0.06 | 0.08 | 0.08 | 0.28 |
Key Financials |
||
| Market Cap | : | ₹ 175.0 Cr |
| Revenue (TTM) | : | ₹ 83.2 Cr |
| Net Profit(TTM) | : | ₹ 4.6 Cr |
| EPS (TTM) | : | ₹ 1.6 |
| P/E (TTM) | : | 38.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BROOKS LABORATORIES | 1.3% | -12.4% | -58.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -3% | -2.6% | 21.3% |
| DIVIS LABORATORIES | -0.5% | 17% | 43.8% |
| TORRENT PHARMACEUTICALS | 0.6% | 2.7% | 35.5% |
| CIPLA | -2.2% | 0.8% | -2.4% |
| DR REDDYS LABORATORIES | -1.1% | -1.6% | -0.8% |
| MANKIND PHARMA | -1% | -3.7% | -1.9% |
| LUPIN | -0.8% | -7.5% | 16.6% |
| ZYDUS LIFESCIENCES | -4.1% | -0.9% | 21.9% |
BROOKS LABORATORIES Revenues
[BOM: 533543|NSE : BROOKS]
| Y-o-Y | 3.86 % |
| 5 Yr CAGR | 1.68 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹83 Cr | 3.86 | |
| Mar2025 | ₹79 Cr | 25.76 | |
| Mar2024 | ₹63 Cr | -30.68 | |
| Mar2023 | ₹91 Cr | 18.04 | |
| Mar2022 | ₹77 Cr | - | |
BROOKS LABORATORIES Operating Profit
[BOM: 533543|NSE : BROOKS]
| Y-o-Y | -56.33 % |
| 5 Yr CAGR | 26.59 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.34 Cr | -56.33 | |
| Mar2025 | ₹3.06 Cr | Positive | |
| Mar2024 | ₹-26 Cr | Negative | |
| Mar2023 | ₹-14 Cr | Negative | |
| Mar2022 | ₹0.52 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -57.92 % |
| 5 Yr CAGR | 24.70 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 1.62% | -57.92 | |
| Mar2025 | 3.85% | Positive | |
| Mar2024 | -41.8% | Negative | |
| Mar2023 | -15.63% | Negative | |
| Mar2022 | 0.67% | - | |
BROOKS LABORATORIES Profit After Tax
[BOM: 533543|NSE : BROOKS]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹-9.97 Cr | Negative | |
| Mar2025 | ₹-20 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-11 Cr | Negative | |
| Mar2022 | ₹-19 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 28.67 % | Positive | |
| Mar2025 | -12.07 % | Negative | |
| Mar2024 | -24.65 % | Negative | |
| Mar2023 | -49.12 % | Negative | |
| Mar2022 | -21.18 % | - | |
BROOKS LABORATORIES Earnings Per Share (EPS)
[BOM: 533543|NSE : BROOKS]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.35 | Positive | |
| Mar2025 | ₹-3.38 | Negative | |
| Mar2024 | ₹-7.46 | Negative | |
| Mar2023 | ₹-8.46 | Negative | |
| Mar2022 | ₹-4.57 | - | |
BROOKS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 533543|NSE : BROOKS]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 21.72% | Positive | |
| Mar2025 | -10.03% | Negative | |
| Mar2024 | -24.92% | Negative | |
| Mar2023 | -37.83% | Negative | |
| Mar2022 | -18.72% | - | |
BROOKS LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹59.3 |
| Current MarketCap | : | ₹ 175.0 Cr |
| Updated EOD on | : | Aug 18,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BROOKS LABORATORIES | 1.3% |
-12.4% |
-58.8% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
BROOKS LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about BROOKS LABORATORIES Financials
How the annual revenues of BROOKS LABORATORIES have changed ?
The Revenues of BROOKS LABORATORIES have increased by 3.86% YoY .
How the Earnings per Share (EPS) of BROOKS LABORATORIES have changed?
The Earnings Per Share (EPS) of BROOKS LABORATORIES has increased by Positive YoY .
Check out Intrinsic Value of Peers of BROOKS LABORATORIES
Compare Stock Analytics of Peers of BROOKS LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
